Thermo Fisher Scientific Inc. (TMO) Q1 2026 Earnings Call Transcript
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) were down more than 7.5% on Thursday after investors weighed a stronger-than-expected quarterly profit against muted underlying growth and
TMO beats Q1 EPS and revenue estimates with steady growth, yet shares slip 4% in pre-market after results and mixed segment performance.
Although the revenue and EPS for Thermo Fisher (TMO) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall St
Thermo Fisher Scientific (TMO) came out with quarterly earnings of $5.44 per share, beating the Zacks Consensus Estimate of $5.2 per share. This compares to earnings of $5.15 per share a year ago.
Shares of Thermo Fisher Scientific Inc (NYSE:TMO, XETRA:TN8) were down more than 7.5% on Thursday after investors weighed a stronger-than-expected quarterly...
Thermo Fisher Scientific on Thursday reported first-quarter profit and revenue above Wall Street estimates, as growth ​in its laboratory products and biopharma services business ‌helped offset sof
WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 28, 2026. First
Caprock Group LLC lifted its holdings in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 21.2% in the undefined quarter, according to the company in its most recent disclosure with the Securiti
Boston Trust Walden Corp lifted its stake in shares of Thermo Fisher Scientific Inc. (NYSE: TMO) by 9.7% during the fourth quarter, according to the company in its most recent filing with the Securiti
AE Wealth Management LLC decreased its position in Thermo Fisher Scientific Inc. (NYSE: TMO) by 92.4% during the undefined quarter, according to its most recent filing with the SEC. The institutional
Thermo Fisher Scientific (TMO) remains a high-quality, stable business, but its stock is currently overvalued relative to its growth outlook. TMO reported FY25 revenue growth of 3.9% and EPS growth of
Evaluate the expected performance of Thermo Fisher (TMO) for the quarter ended March 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metri
On April 20, 2026, we present a detailed DCF analysis for Thermo Fisher Scientific Inc (TMO). The stock has shown a price performance of +6.2% over the past wee
Atlantic Edge Private Wealth Management LLC boosted its holdings in Thermo Fisher Scientific Inc. (NYSE: TMO) by 24.8% in the fourth quarter, according to the company in its most recent Form 13F filin
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE